PDC6I_MOUSE - dbPTM
PDC6I_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PDC6I_MOUSE
UniProt AC Q9WU78
Protein Name Programmed cell death 6-interacting protein
Gene Name Pdcd6ip
Organism Mus musculus (Mouse).
Sequence Length 869
Subcellular Localization Cytoplasm, cytosol . Melanosome . Cytoplasm, cytoskeleton, microtubule organizing center, centrosome . Secreted, exosome . Cell junction, tight junction . Midbody, Midbody ring . Colocalized with CEP55 in the midbody during cytokinesis and at centros
Protein Description Multifunctional protein involved in endocytosis, multivesicular body biogenesis, membrane repair, cytokinesis, apoptosis and maintenance of tight junction integrity. Class E VPS protein involved in concentration and sorting of cargo proteins of the multivesicular body (MVB) for incorporation into intralumenal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome. Binds to the phospholipid lysobisphosphatidic acid (LBPA) which is abundant in MVBs internal membranes. The MVB pathway requires the sequential function of ESCRT-O, -I,-II and -III complexes. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis. Adapter for a subset of ESCRT-III proteins, such as CHMP4, to function at distinct membranes. Required for completion of cytokinesis. May play a role in the regulation of both apoptosis and cell proliferation. Regulates exosome biogenesis in concert with SDC1/4 and SDCBP (By similarity). By interacting with F-actin, PARD3 and TJP1 secures the proper assembly and positioning of actomyosin-tight junction complex at the apical sides of adjacent epithelial cells that defines a spatial membrane domain essential for the maintenance of epithelial cell polarity and barrier. [PubMed: 27336173]
Protein Sequence MASFIWVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRSALGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKTAAKQYQFASGAFLHIKDTVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPTLAAKQCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKNVASRYDEYVNVKDFSDKINRALTAAKKDNDFIYHDRVPDLKDLDPIGKATLVKPTPVNVPVSQKFTDLFEKMVPVSVQQSLAVFSQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSTSVVEQGGIQTVDQLIKELPELLQRNREILEESLRLLDEEEATDNDLRAKFKDRWQRTPSNDLYKPLRAEGAKFRAVLDKAVQADGQVKERYQSHRDTIALLCKPEPELNAAIPSANPAKTMQGSEVVSVLKSLLSNLDEIKKERESLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRIYGGLTSKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERDELLKDLQQSIAREPSAPSIPPPAYQSSPAAGHAAAPPTPAPRTMPPAKPQPPARPPPPVLPANRVPPASAAAAPAGVGTASAAPPQTPGSAPPPQAQGPPYPTYPGYPGYCQMPMPMGYNPYAYGQYNMPYPPVYHQSPGQAPYPGPQQPTYPFPQPPQQSYYPQQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Acetylation------MASFIWVQL
------CCCEEEEEE
17.10-
11MalonylationFIWVQLKKTSEVDLA
EEEEEECCCCCCCHH
66.9126320211
12PhosphorylationIWVQLKKTSEVDLAK
EEEEECCCCCCCHHH
28.6529550500
13PhosphorylationWVQLKKTSEVDLAKP
EEEECCCCCCCHHHH
44.4926824392
19AcetylationTSEVDLAKPLVKFIQ
CCCCCHHHHHHHHHH
46.3022826441
19UbiquitinationTSEVDLAKPLVKFIQ
CCCCCHHHHHHHHHH
46.30-
23UbiquitinationDLAKPLVKFIQQTYP
CHHHHHHHHHHHHCC
44.42-
31PhosphorylationFIQQTYPSGGEEQAQ
HHHHHCCCCHHHHHH
49.3625338131
40S-nitrosocysteineGEEQAQYCRAAEELS
HHHHHHHHHHHHHHH
1.26-
40S-nitrosylationGEEQAQYCRAAEELS
HHHHHHHHHHHHHHH
1.2621278135
40GlutathionylationGEEQAQYCRAAEELS
HHHHHHHHHHHHHHH
1.2624333276
48AcetylationRAAEELSKLRRSALG
HHHHHHHHHHHHHHC
59.6522826441
48UbiquitinationRAAEELSKLRRSALG
HHHHHHHHHHHHHHC
59.65-
48MalonylationRAAEELSKLRRSALG
HHHHHHHHHHHHHHC
59.6526320211
60AcetylationALGRPLDKHEGALET
HHCCCCHHCCCHHHH
51.7623236377
60UbiquitinationALGRPLDKHEGALET
HHCCCCHHCCCHHHH
51.76-
101UbiquitinationTWKDAFDKGSLFGGS
EEHHCCCCCCCCCHH
43.90-
101AcetylationTWKDAFDKGSLFGGS
EEHHCCCCCCCCCHH
43.9022826441
108PhosphorylationKGSLFGGSVKLALAS
CCCCCCHHHHHHHHH
19.2362170609
209MalonylationKATRDKMKDAIIAKL
HHCHHHHHHHHHHHH
50.1526320211
215AcetylationMKDAIIAKLANQAAD
HHHHHHHHHHHHHHH
37.4122826441
229AcetylationDYFGDAFKQCQYKDT
HHHHHHHHHCCCCCC
52.4622826441
234AcetylationAFKQCQYKDTLPKEV
HHHHCCCCCCCCHHH
20.5422826441
258PhosphorylationIMQANAEYHQSILAK
HHHHCHHHHHHHHHH
11.6225338131
261PhosphorylationANAEYHQSILAKQQK
HCHHHHHHHHHHHHH
13.2725338131
268AcetylationSILAKQQKKFGEEIA
HHHHHHHHHHHHHHH
47.806569569
269AcetylationILAKQQKKFGEEIAR
HHHHHHHHHHHHHHH
55.026568927
285UbiquitinationQHAAELIKNVASRYD
HHHHHHHHHHHHHCH
58.98-
298AcetylationYDEYVNVKDFSDKIN
CHHCCCHHHHHHHHH
48.1023954790
298SuccinylationYDEYVNVKDFSDKIN
CHHCCCHHHHHHHHH
48.1023954790
298UbiquitinationYDEYVNVKDFSDKIN
CHHCCCHHHHHHHHH
48.10-
319PhosphorylationKKDNDFIYHDRVPDL
HHCCCCCCCCCCCCH
9.5429514104
339AcetylationIGKATLVKPTPVNVP
CCCEEEECCCCCCCC
46.4123236377
339MalonylationIGKATLVKPTPVNVP
CCCEEEECCCCCCCC
46.4126320211
350UbiquitinationVNVPVSQKFTDLFEK
CCCCCHHHHHHHHHH
42.60-
421PhosphorylationPQSILTKSTSVVEQG
CHHHHCCCCCHHHCC
22.2226643407
422PhosphorylationQSILTKSTSVVEQGG
HHHHCCCCCHHHCCC
27.3926643407
423PhosphorylationSILTKSTSVVEQGGI
HHHCCCCCHHHCCCH
31.1226824392
464PhosphorylationLLDEEEATDNDLRAK
HCCHHHCCCCHHHHH
38.3226525534
479PhosphorylationFKDRWQRTPSNDLYK
HHHHHCCCCCCCCCH
18.9028066266
481PhosphorylationDRWQRTPSNDLYKPL
HHHCCCCCCCCCHHH
42.2228066266
486AcetylationTPSNDLYKPLRAEGA
CCCCCCCHHHHHCCH
44.8922826441
501MalonylationKFRAVLDKAVQADGQ
HHHHHHHHHHHCCCH
46.4226320211
501UbiquitinationKFRAVLDKAVQADGQ
HHHHHHHHHHHCCCH
46.42-
627UbiquitinationKKQEGLLKNIQVSHQ
HHCCCHHHHHHCCHH
57.98-
638UbiquitinationVSHQEFSKMKQSNNE
CCHHHHHHHHHCCCH
56.27-
640UbiquitinationHQEFSKMKQSNNEAN
HHHHHHHHHCCCHHH
55.07-
690AcetylationILVRFQNKCSDIVFA
HHHHHHHHCCCCEEE
25.0822826441
692PhosphorylationVRFQNKCSDIVFARK
HHHHHHCCCCEEECC
31.7926643407
700PhosphorylationDIVFARKTERDELLK
CCEEECCHHHHHHHH
30.6026643407
707UbiquitinationTERDELLKDLQQSIA
HHHHHHHHHHHHHHH
69.85-
712PhosphorylationLLKDLQQSIAREPSA
HHHHHHHHHHHCCCC
12.7823984901
718PhosphorylationQSIAREPSAPSIPPP
HHHHHCCCCCCCCCC
48.3225619855
721PhosphorylationAREPSAPSIPPPAYQ
HHCCCCCCCCCCCCC
47.6623984901
727PhosphorylationPSIPPPAYQSSPAAG
CCCCCCCCCCCCCCC
18.0725619855
729PhosphorylationIPPPAYQSSPAAGHA
CCCCCCCCCCCCCCC
26.1325619855
730PhosphorylationPPPAYQSSPAAGHAA
CCCCCCCCCCCCCCC
11.7523984901
734PhosphorylationYQSSPAAGHAAAPPT
CCCCCCCCCCCCCCC
17.0524719451
741PhosphorylationGHAAAPPTPAPRTMP
CCCCCCCCCCCCCCC
30.9025619855
745MethylationAPPTPAPRTMPPAKP
CCCCCCCCCCCCCCC
45.84-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of PDC6I_MOUSE !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PDC6I_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PDC6I_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PDC6I_MOUSE

loading...

Related Literatures of Post-Translational Modification

TOP